Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
The inflammasome potentiates influenza/Staphylococcus aureus superinfection in mice
Keven M. Robinson, Krishnaveni Ramanan, Michelle E. Clay, Kevin J. McHugh, Matthew J. Pilewski, Kara L. Nickolich, Catherine Corey, Sruti Shiva, Jieru Wang, Radhika Muzumdar, John F. Alcorn
Keven M. Robinson, Krishnaveni Ramanan, Michelle E. Clay, Kevin J. McHugh, Matthew J. Pilewski, Kara L. Nickolich, Catherine Corey, Sruti Shiva, Jieru Wang, Radhika Muzumdar, John F. Alcorn
View: Text | PDF
Research Article Immunology Pulmonology

The inflammasome potentiates influenza/Staphylococcus aureus superinfection in mice

  • Text
  • PDF
Abstract

Secondary bacterial respiratory infections are commonly associated with both acute and chronic lung injury. Influenza complicated by bacterial pneumonia is an effective model to study host defense during pulmonary superinfection due to its clinical relevance. Multiprotein inflammasomes are responsible for IL-1β production in response to infection and drive tissue inflammation. In this study, we examined the role of the inflammasome during viral/bacterial superinfection. We demonstrate that ASC–/– mice are protected from bacterial superinfection and produce sufficient quantities of IL-1β through an apoptosis-associated speck-like protein containing CARD (ASC) inflammasome–independent mechanism. Despite the production of IL-1β by ASC–/– mice in response to bacterial superinfection, these mice display decreased lung inflammation. A neutrophil elastase inhibitor blocked ASC inflammasome–independent production of IL-1β and the IL-1 receptor antagonist, anakinra, confirmed that IL-1 remains crucial to the clearance of bacteria during superinfection. Delayed inhibition of NLRP3 during influenza infection by MCC950 decreases bacterial burden during superinfection and leads to decreased inflammatory cytokine production. Collectively, our results demonstrate that ASC augments the clearance of bacteria, but can also contribute to inflammation and mortality. ASC should be considered as a therapeutic target to decrease morbidity and mortality during bacterial superinfection.

Authors

Keven M. Robinson, Krishnaveni Ramanan, Michelle E. Clay, Kevin J. McHugh, Matthew J. Pilewski, Kara L. Nickolich, Catherine Corey, Sruti Shiva, Jieru Wang, Radhika Muzumdar, John F. Alcorn

×

Figure 3

Mice lacking the ASC inflammasome produce IL-1β through inflammasome-independent mechanisms and IL-1β is crucial to the effective clearance of bacteria during superinfection.

Options: View larger image (or click on image) Download as PowerPoint
Mice lacking the ASC inflammasome produce IL-1β through inflammasome-ind...
C57BL/6 and ASC–/– mice were infected with influenza A/PR/8/34 or vehicle for 6 days, and then challenged with 108 CFU of methicillin-sensitive Staphylococcus aureus (MSSA) or vehicle for 24 hours. (A) IL-1β concentrations in bronchoalveolar lavage fluid as measured by Bio-Plex immunoassay (n = 11–12). (B) IL-1β concentrations in lung homogenate as measured by ELISA (n = 7–8). C57BL/6 and ASC–/– mice were infected with influenza for 6 days, and then challenged with methicillin-resistant S. aureus (MRSA) for 24 hours. Mice received silvestat, 10 μg/g i.p. or vehicle control, on days 4–6 after influenza. (C) Bacterial colony counts in lung homogenate (n = 9). (D) IL-1β concentrations in lung homogenate as measured by Bio-Plex immunoassay (n = 6). (E) Gene expression of type 17 immunity–related antimicrobial peptides (n = 7–8). C57BL/6 and ASC–/– mice were infected with influenza for 6 days, and then challenged with MSSA for 24 hours. Mice received anakinra, 600 μg in 200 μl of PBS i.p., on days 0–6 after influenza. (F) Bacterial colony counts in lung homogenate (n = 8). *P < 0.05 versus Flu/SA by 1-way ANOVA or unpaired t test. Data points reflect individual values ± SEM. Each experiment was independently performed at least twice and data are shown from combined experiments. NS, not significant.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts